Decoding immunogenic cell death from a dendritic cell perspective
Immunological Reviews · 2024-01 · 321 (1) · 350-370
DOI: 10.1111/imr.13301 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 13.12.2023. Verfasst von Sophie Janssens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for ER Stress and Inflammation, Center for Inflammation Research, VIB, Ghent, Belgium. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Neoplasms. Die Arbeit wurde bisher 95-mal zitiert (Crossref) und nennt 249 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bijzonder Onderzoeksfonds UGent, EOS MetaNiche consortium, EOS-DECODE consortium.
Abstract (Originalsprache)
Dendritic cells (DCs) are myeloid cells bridging the innate and adaptive immune system. By cross‐presenting tumor‐associated antigens (TAAs) liberated upon spontaneous or therapy‐induced tumor cell death to T cells, DCs occupy a pivotal position in the cancer immunity cycle. Over the last decades, the mechanisms linking cancer cell death to DC maturation, have been the focus of intense research. Growing evidence supports the concept that the mere transfer of TAAs during the process of cell death is insufficient to drive immunogenic DC maturation unless this process is coupled with the release of immunomodulatory signals by dying cancer cells. Malignant cells succumbing to a regulated cell death variant called immunogenic cell death (ICD), foster a proficient interface with DCs, enabling their immunogenic maturation and engagement of adaptive immunity against cancer. This property relies on the ability of ICD to exhibit pathogen‐mimicry hallmarks and orchestrate the emission of a spectrum of constitutively present or de novo‐induced danger signals, collectively known as damage‐associated molecular patterns (DAMPs). In this review, we discuss how DCs perceive and decode danger signals emanating from malignant cells undergoing ICD and provide an outlook of the major signaling and functional consequences of this interaction for DCs and antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for ER Stress and Inflammation, Center for Inflammation Research, VIB, Ghent, Belgium.
- Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
- Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.
ORCID-Profile: Patrizia Agostinis
Förderung
- Bijzonder Onderzoeksfonds UGent
- EOS MetaNiche consortium
- EOS-DECODE consortium
- ERC Co-G DC-RIDDLE
- Fonds Wetenschappelijk Onderzoek
- iBOF ATLANTIS network
- KU Leuven InterAction consortium
- Stichting Tegen Kanker
Zitieren
APA
Janssens, S., Rennen, S., & Agostinis, P. (2024). Decoding immunogenic cell death from a dendritic cell perspective. Immunological Reviews, 321(1), 350-370. https://doi.org/10.1111/imr.13301
Vancouver
Janssens S, Rennen S, Agostinis P. Decoding immunogenic cell death from a dendritic cell perspective. Immunological Reviews. 2024;321(1):350-370. doi:10.1111/imr.13301
BibTeX
@article{Janssens2024,
author = {Janssens, Sophie and Rennen, Sofie and Agostinis, Patrizia},
title = {Decoding immunogenic cell death from a dendritic cell perspective},
journal = {Immunological Reviews},
year = {2024},
volume = {321},
number = {1},
pages = {350--370},
doi = {10.1111/imr.13301}
}
EUVIMED